ovarian cancer

October 8, 2018October 10, 2018

Ovarian Cancer Treatment Named Breakthrough Therapy with Potential in Advanced Prostate Cancers

News

An approved therapy for advanced ovarian cancer — Rubraca (rucaparib) by Clovis Oncology — has been designated a breakthrough therapy by the U.S. Food and Drug Administration as a potential treatment for metastatic castration-resistant ... Read more

February 2, 2018

New Compounds May Counteract Chemotherapy Resistance in Prostate Cancer Cells

News

Researchers at Southern Methodist University discovered three new small molecules that overcome the resistance to chemotherapy observed in patients with prostate, breast, and ovarian cancer. The study, “Targeted inhibitors of P-glycoprotein ... Read more

September 9, 2016

Loss of Commonly Mutated Gene in Prostate Tumors May Be Potential Biomarker for Targeted Treatment

News

A new research study found that the loss of CHD1, one of the most commonly mutated genes in prostate tumors, may be a potential biomarker for targeted prostate cancer therapy. In ... Read more